RACHEL DOERR: Open Payments
NPI 1891070371 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,088 in 19 payments from 12 companies in 2025. Trend: 2023 $850 · 2024 $1,205 · 2025 $2,088
Food & beverage: $1,300Travel & lodging: $788
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 6 | $1,294 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Janssen Biotech, Inc. | 1 | $104 |
| SpringWorks Therapeutics, Inc. | 1 | $104 |
| Teva Pharmaceuticals USA, Inc. | 1 | $84 |
| Abbott Laboratories | 2 | $47 |
| PFIZER INC. | 1 | $42 |
| Organogenesis Inc. | 2 | $31 |
Products named: Kerecis SurgiClose, SAPHNELO, Auvelity, ZENPEP, TREMFYA, GOMEKLI, AUSTEDO XR, TRICLIP.
Industry payments across AZ — which companies pay providers there.
